Oncology

With an ongoing phase 3 study, pralsetinib seems to be a promising candidate for the treatment of different types of cancer because of the presence of oncogenic rearranged during transfection) fusions.

Improved SARS-CoV-2 antibody levels seen in most groups.

Ovarian cancer is the 8th most common cancer in women and the most fatal gynaecological cancer in Canada. Nonetheless, we can be optimistic about the future, as innovations bring new approaches that could have an impact on present and future patients. Read more.

Paclitaxel and docetaxel may increase the risk of eye adverse events in women who receive these drugs for cancer

Our clinical writer Lu-Ann Murdoch keeps up to date on all the latest drug news in Canada. This summer she's highlighted many new indications for existing drugs including Zeposia, Jardiance and Gardasil 9.

Canadian researchers find risk is no higher than with aromatase inhibitors.

Restrictions, fears of use arise as fallout from recent Roe v. Wade decision

A new study explores how breast cancer cells inhibit insulin production.